Prosecution Insights
Last updated: November 08, 2026

Sigma-aldrich Co. LLC

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Sigma-aldrich Co. LLC manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area with 4 pending office actions currently under review. The data shows that these matters are distributed across 4 distinct art units, which suggests that the pending applications cover a variety of technical subjects within the field. This distribution requires the applicant to address the specific standards and guidelines of 4 different administrative divisions.

The prosecution involves 4 distinct examiners, meaning that each pending matter is being evaluated by a different individual. VISHNYAKOVA, ELENA VLADIMIROVNA is the busiest examiner for this portfolio, currently handling 1 pending office action. Because no single examiner is responsible for more than 1 pending office action, the prosecution strategy must be tailored to the individual preferences and examination styles of 4 separate people.

The lack of overlap among the 4 distinct examiners and 4 distinct art units indicates a decentralized prosecution environment. Insights gained from one of the 4 pending office actions may not be applicable to the others. Practitioners should focus on the unique technical requirements of each art unit and the specific feedback from each examiner to move the portfolio forward effectively.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (60%)
2
Medium (40%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (20%)
§103 only2 (40%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VISHNYAKOVA, ELENA VLADIMIROVNA 1 68.3% +46.6%
PARISI, JESSICA DANIELLE 1 73.5% +35.9%
HORLICK, KENNETH R 1 79.0% +15.3%
NGUYEN, CAM N 1 84.9% +12.2%
HA, JULIE 1 75.7% +44.1%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17905907 EFFICIENT PREPARATION OF DOLASTATIN AND AURISTATIN ANALOGS THROUGH A COMMON INTERMEDIATE HA, JULIE 22d
18470565 DEGENERATE OLIGONUCLEOTIDES AND THEIR USES PARISI, JESSICA DANIELLE —
18253464 PRE-COATINGS FOR BIOCOMPATIBLE SOLID PHASE MICROEXTRACTION DEVICES NGUYEN, CAM N —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17905907 EFFICIENT PREPARATION OF DOLASTATIN AND AURISTATIN ANALOGS THROUGH A COMMON INTERMEDIATE HA, JULIE 22d
18558693 CHEMICALLY LINKABLE NUCLEAR TARGETING TAGS VISHNYAKOVA, ELENA VLADIMIROVNA —
18470565 DEGENERATE OLIGONUCLEOTIDES AND THEIR USES PARISI, JESSICA DANIELLE —
18470603 METHODS FOR NEXT GENERATION GENOME WALKING AND RELATED COMPOSITIONS AND KITS HORLICK, KENNETH R —
18253464 PRE-COATINGS FOR BIOCOMPATIBLE SOLID PHASE MICROEXTRACTION DEVICES NGUYEN, CAM N —

Top Art Units

Art UnitApps
1691 1
1639 1
1681 1
1736 1
1654 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18558693 CHEMICALLY LINKABLE NUCLEAR TARGETING TAGS VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §103 Non-Final OA — Pending Nov 02, 2023
18470565 DEGENERATE OLIGONUCLEOTIDES AND THEIR USES PARISI, JESSICA DANIELLE 1639 §101§102§112 Non-Final OA — Pending Sep 20, 2023
18470603 METHODS FOR NEXT GENERATION GENOME WALKING AND RELATED COMPOSITIONS AND KITS HORLICK, KENNETH R 1681 §103 Non-Final OA — Pending Sep 20, 2023
18253464 PRE-COATINGS FOR BIOCOMPATIBLE SOLID PHASE MICROEXTRACTION DEVICES NGUYEN, CAM N 1736 §102§103§112 Non-Final OA — Pending May 18, 2023
17905907 EFFICIENT PREPARATION OF DOLASTATIN AND AURISTATIN ANALOGS THROUGH A COMMON INTERMEDIATE HA, JULIE 1654 §102§112 Final Rejection 22d Pending Sep 08, 2022

Managing Sigma-aldrich Co. LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Sigma-aldrich Co. LLC have?

Sigma-aldrich Co. LLC has 5 pending office actions as of November 2026, spread across 5 art units and 5 examiners.

Which USPTO examiner handles the most Sigma-aldrich Co. LLC applications?

Elena Vladimirovna Vishnyakova has the most, with 1 of Sigma-aldrich Co. LLC's pending office actions.

What technology area are Sigma-aldrich Co. LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month